Justin Klee
Vermögen: 51 Mio $ am 31.05.2026
Vermögen: 51 Mio $ am 31.05.2026
Justin Klee is the founder of Amylyx Pharmaceuticals, Inc., founded in 2013, and holds the title of Co-Chief Executive Officer & Executive Director since 2014.
Former job includes Member at Harvard Medical School.
Education includes undergraduate degree from Brown University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 10.04.2026 | 3.583.481 ( 3,22 % ) | 51 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| AMYLYX PHARMACEUTICALS, INC. | Gründer | 01.01.2013 |
| Unternehmen | Position | Ende |
|---|---|---|
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 3 |
|---|---|
Brown University
Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amylyx Pharmaceuticals, Inc.
Amylyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products to cure neurodegenerative diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen